Medpace Holdings Inc reports results for the quarter ended in March - Earnings Summary

Medpace Holdings

22/04/2024 22:53

* Medpace Holdings Inc  MEDP.OQ  reported quarterly adjusted
earnings of $3.20​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of $2.27.  The mean expectation of six analysts for
the quarter was for earnings of $2.47 per share. Wall Street
expected results to range from $2.43  to $2.54 per share.
    * Revenue rose 17.7% to $511.04 million from a year ago;
analysts
expected $512.59 million. 
    * Medpace Holdings Inc's reported EPS for the quarter was
$3.20​.
    * The company reported quarterly net income of $102.59
million.
    * Medpace Holdings Inc shares had fallen by 8.0% this
quarter and
gained 21.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Medpace Holdings
Inc is $446.00 
This summary was machine generated from LSEG data April 22 at
09:53 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      2.47           3.20           Beat
 Dec. 31 2023      2.22           2.46           Beat
 Sep. 30 2023      2.05           2.22           Beat
 Jun. 30 2023      1.91           1.93           Beat